Taft Chicago partner Roshan Shrestha, Ph.D., will be presenting at the 11th Annual Pharma IPR Conference in Mumbai, India, on Sept. 14. The conference provides the opportunity for IP leaders and law firms to share insight on achieving further growth, best practices, and recent trends in the Pharma IPR space. Shrestha’s presentation “Section 112 Challenges – Amgen v. Sanofi” will cover details about the case, its history, and implications on generic manufacturer’s enablement and written description defenses against asserted patents.

For more information, click here.

Shrestha focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution, and opinion work in the chemical, pharmaceutical, and electronic material arts. He has a broad scope of pharmaceutical and life sciences capabilities, including Hatch-Waxman litigation and inter partes review proceedings at the USPTO. Shrestha has been recognized by Super Lawyers^® as a Rising Star and named to Law Bulletin’s “40 Illinois Attorneys Under 40 to Watch” in 2016.